AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
22,300
-50 (-0.22%)
At close: Aug 28, 2025
-0.22%
Market Cap503.23B
Revenue (ttm)8.97B
Net Income (ttm)959.45M
Shares Out22.57M
EPS (ttm)42.94
PE Ratio524.50
Forward PE69.69
Dividendn/a
Ex-Dividend Daten/a
Volume184,276
Average Volume254,854
Open22,400
Previous Close22,350
Day's Range21,950 - 22,550
52-Week Range11,980 - 25,900
Beta1.54
RSI60.63
Earnings Daten/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.